ABSTRACT-A noncompetitive NMDA antagonist MK-801 (0.03-0.3 mg/kg, i.p.) increased the response rate of mice trained under the discrete shuttle avoidance situa tion to a degree similar to the increase by methamphetamine (0.1-1 mg/kg, i.p.). The cholecystokinin-like decapeptide ceruletide significantly reduced the response-in creasing effect of MK-801 (0.1 mg/kg) at 0.001 pg/kg; however, only 10 pg/kg of ceruletide, which per se inhibited the response, attenuated that of methamphetamine (0.3 mg/kg). The coadministration of MK-801 (0.1 mg/kg) and methamphetamine (0.3 mg/kg) produced no potentiation of the effect, and almost the same effect was main tained even after the additional administration of ceruletide (0.1 ,ug/kg).
A noncompetitive NMDA antagonist MK 801, (+)-5-methyl-10,11-dihydro-5H-dibenzo [a,d]-cyclohepten-5,10-imine (1), increases the ambulatory activity of mice, produces an ipsi lateral turning in the rat with unilateral nigro striatal lesion (2) , and reduces the haloperidol induced catalepsy (3), indicating that MK-801 possesses an indirect agonistic action on cen tral dopaminergic systems, as amphetamines do. Dimpfel and Spuler (4) also reported an activation of the dopaminergic transmission by MK-801 in terms of brain field potentials. However, Clineschmidt et al. (2) also reported that the MK-801 and methamphetamine-in duced increases in the mouse's ambulatory activity were selectively inhibited by reserpine and a-methyl-p-tyrosine, respectively. Such a result indicates that the characteristics of MK 801 differ from those of amphetamines. Thus, a further study was needed to characterize the behavior stimulant effect of MK-801.
In this study, we used the discrete shuttle avoidance response in mice to further assess the effect of a comparatively lower dose of MK-801 through combined administration with the cholecystokinin-like decapeptide ceruletide (5) . The systemic administration of this pep tide, at over 10 ,ug/kg, significantly reduced the ambulation-increasing and response-in creasing effects of methamphetamine (0.5-2 mg/kg) (6, 7) . In particular, the shuttle avoid ance was more convenient than the ambula tory activity for detecting the interaction be tween a low dose of methamphetamine and ceruletide.
The experimental animals used were male mice of the ddY strain (Japan Laboratory Animals). They were subjected to the avoid ance test at the age of 8 weeks. These mice had been bred in a room with controlled con ditions (12-hr light-dark schedule; light period of 6:00-18:00, temperature; 22 ± 1°C, rela tive humidity; 50 ± 5%) with free access to food and tap water.
The experimental apparatus (experimental chamber, behavior-controlling and data-re cording apparatus; GT-8450, De CARES GT M5 and TIDP-10, respectively; O'Hara & Co.) were the same as those used in our pre vious study (7) . The temporal parameters of discrete avoidance schedule were an intertrial interval of 25 sec and a warning duration of 5 sec. An electric foot shock of 100 V, 0.3 mA, 50 Hz AC was delivered through the floor grid of the chamber as the unconditioned stim ulus for 0.3 sec during the drug-testing ses sions. Each session consisted of a 30-min per formance in which 60 avoidance trials were carried out at intervals of 30 sec. The indices of the avoidance response were the response rate (frequency of shuttles) and the avoidance rate (number of avoidance responses/number of avoidance trials). All experiments were held between 9:00 -12:00.
The drugs used were MK-801 hydromaleate (Merck/Banyu), methamphetamine HCI (Dainippon Pharm.) and ceruletide diethyl amine (Shionogi Co.). These drugs were dis solved in physiological saline, and the doses were expressed in terms of the salt forms. The drug solutions were administered intraperi toneally (i.p.) at a fixed volume of 0.1 ml/10 g body weight.
A preliminary experiment and the previous studies (6, 7) demonstrated that the inhibitory action of ceruletide on the ambulation and response-increasing effects of methamphet amine appeared within a few min, and almost the same inhibitory action persisted for longer than 3 hr but not for 24 hr. Therefore, the drug administrations, both in the single and combined administration tests, were conducted immediately before the sessions, and there after the avoidance response of each mouse was observed for 30 min. The drug testing-ses sions were held at intervals of 3-4 days; and the days before, saline was administered as the control sessions. In this experiment, 3 groups of 10 mice were used; the 1st and 2nd groups were used for evaluation of MK-801 and methamphetamine, respectively, and the 3rd one was used for testing the interaction among MK-801, methamphetamine and ceruletide.
In each drug testing, the doses of drugs were changed from the lower to the higher in 5 mice, and the reverse order in the other 5 mice.
The overall response rate and % of avoid ance during the sessions were first analyzed by ANOVA.
In a case of significant variance, comparisons between individual data were conducted by the paired t-test. When P values were equal to or less than 0.05, the two values were considered to be significantly different. As presented in Fig. 1 , both MK-801 and methamphetamine increased the response rate of mice in a dose-dependent manner. The dose-effect relation curves revealed that the response-increasing effect of MK-801 was about 3 times as potent as that of metham phetamine.
Furthermore, MK-801, at 0.3 mg/kg but not at 0.1 mg/kg, produced an ataxia. Therefore, 0.1 mg/kg of MK-801 and 0.3 mg/kg of methamphetamine were used in the coadministration test as the equivalent and optimum doses for increasing the response rate. On the other hand, ceruletide at 0.001 1 ug/kg produced no significant change in the response rate; and at up to 10 mg/kg, it de creased significantly.
Since the mean overall % of avoidance was always higher than 95%, and no significant change was produced in all experiments, the data are not shown in the figures.
As shown in Fig. 2 , the response-increasing effect of MK-801 and methamphetamine was reduced by ceruletide in a dose-dependent manner, although the activities were much different. The response-increasing effects of MK-801 was significantly reduced by only 0.001 u g/kg of ceruletide, and 0.1 mg/kg was effective for returning the rate to the saline alone administered level. Whereas, up to 10 ,u g/kg, which per se inhibited significantly the response rate, was required to significantly, but partially, reduce the effect of metham phetamine. Even at 100,ug/kg of ceruletide, the methamphetamine-induced increase in the response rate could not be returned to the control level.
The coadministration of MK-801 (0.1 mg/kg) and methamphetamine (0.3 mg/kg) produced neither potentiation nor reduction in the response-increasing effect. Moreover, ceruletide (0.1 pg/kg) was without effect for modification of the effect of the coadminis tered MK-801 (0.1 mg/kg) and methamphet amine (0.3 mg/kg) (data not shown).
A number of researchers have reported the antiamphetamine effect of ceruletide (6 8). The present experiment also confirmed such action, and the effective doses of ceruletide for producing the significant reduction of meth amphetamine's effects were almost com parable between the present and previous ex periments. The response-increasing effect of MK-801 at 0.1 mg/kg was almost equivalent with that of 0.3 mg/kg of methamphetamine. However, it is notable that the effective dose of ceruletide to significantly reduce MK-801's effect was only 0.001 ,ug/kg, i.e., the antago nistic activity of ceruletide for MK-801 was about 10000 times as strong as that for methamphetamine.
It has been suggested that peripherally administered ceruletide and/or its analogs sup press the dopaminergic systems with mecha nisms different from the receptor blockade by antipsychotic drugs, i.e., a reduction of dopa mine release by a modification of the afferent transmission through the vagus nerve and/or by a direct action on the dopaminergic neurons after passing the blood-brain barrier (9) (10) (11) (12) (13) (14) (15) . On the other hand, the behavior sti mulant effect of methamphetamine appears through an enhancement of the release and/or inhibition of dopamine reuptake. If the be havior stimulant effects of MK-801 and methamphetamine are produced by a common mechanism, the antagonistic action of ceruletide on the behavioral effects of MK-801 and methamphetamine should appear in almost the same degree. However, the activity of ceruletide for MK-801 was 10000 times as potent as that for methamphetamine. This re sult indicates the differential characteristics be tween MK-801 and methamphetamine-in duced enhancement of the dopaminergic trans mission. This may be also supported by the facts that ceruletide can completely inhibit the MK-801-induced increase in the mouse's ambulatory activity and the response rate, although it only partially reduced the behavior stimulation by methamphetamine even at large doses (up to 10,ug/kg), and there was no clear dose-effect relationship in the interaction between ceruletide and methamphetamine as demonstrated in the present and previous studies (6, 7) . MK-801, at 0.1 mg/kg, did not potentiate the stimulant effect of methamphet amine by means of the present avoidance situation and ambulatory activity in mice (un published data, H. Kuribara).
It has been suggested that MK-801 and amphetamines-induced increase in the mouse's ambulatory activity were differentially reduced by reserpine and a -methyl-p-tyrosine, respec tively (2) . Such a result also supports the idea 
